Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Hyperplasia | 11 | 2024 | 516 | 2.980 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 6 | 2024 | 74 | 2.540 |
Why?
|
Prostate | 10 | 2024 | 1765 | 2.260 |
Why?
|
5-alpha Reductase Inhibitors | 4 | 2024 | 112 | 1.030 |
Why?
|
Estrogen Receptor alpha | 3 | 2024 | 581 | 0.810 |
Why?
|
Membrane Proteins | 6 | 2024 | 7876 | 0.800 |
Why?
|
Metformin | 4 | 2017 | 909 | 0.790 |
Why?
|
Androstenes | 1 | 2020 | 177 | 0.620 |
Why?
|
DNA Methylation | 7 | 2020 | 4428 | 0.590 |
Why?
|
Prostatic Diseases | 1 | 2017 | 57 | 0.580 |
Why?
|
Epigenesis, Genetic | 4 | 2020 | 3833 | 0.530 |
Why?
|
Cell Proliferation | 8 | 2024 | 10474 | 0.530 |
Why?
|
Estrogens | 2 | 2020 | 1536 | 0.510 |
Why?
|
Epithelial Cells | 3 | 2024 | 3703 | 0.460 |
Why?
|
Aromatase | 3 | 2020 | 147 | 0.450 |
Why?
|
Estradiol | 2 | 2018 | 1951 | 0.440 |
Why?
|
Androgens | 1 | 2020 | 1281 | 0.400 |
Why?
|
Prostatectomy | 5 | 2020 | 1786 | 0.390 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2015 | 622 | 0.390 |
Why?
|
Urinary Bladder Diseases | 1 | 2012 | 166 | 0.380 |
Why?
|
Drugs, Chinese Herbal | 2 | 2020 | 146 | 0.370 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 257 | 0.370 |
Why?
|
Somatomedins | 1 | 2011 | 179 | 0.360 |
Why?
|
Urinary Bladder, Overactive | 1 | 2012 | 117 | 0.350 |
Why?
|
Neovascularization, Pathologic | 3 | 2015 | 2631 | 0.310 |
Why?
|
Growth Hormone | 1 | 2011 | 573 | 0.310 |
Why?
|
Testosterone | 1 | 2017 | 2491 | 0.270 |
Why?
|
Aloe | 1 | 2005 | 2 | 0.250 |
Why?
|
Promoter Regions, Genetic | 6 | 2020 | 5797 | 0.250 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4352 | 0.250 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2019 | 2195 | 0.240 |
Why?
|
Radiation-Protective Agents | 1 | 2005 | 88 | 0.240 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2056 | 0.240 |
Why?
|
Plants, Medicinal | 1 | 2005 | 167 | 0.240 |
Why?
|
Stromal Cells | 3 | 2020 | 1336 | 0.230 |
Why?
|
Prostatic Neoplasms | 6 | 2022 | 11101 | 0.200 |
Why?
|
Obesity | 2 | 2020 | 13090 | 0.170 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2023 | 526 | 0.170 |
Why?
|
3T3-L1 Cells | 1 | 2020 | 207 | 0.170 |
Why?
|
Transurethral Resection of Prostate | 1 | 2020 | 77 | 0.160 |
Why?
|
Finasteride | 1 | 2020 | 86 | 0.160 |
Why?
|
Polysaccharides | 1 | 2005 | 1024 | 0.150 |
Why?
|
Cell Line, Transformed | 2 | 2017 | 866 | 0.150 |
Why?
|
Cystectomy | 2 | 2019 | 603 | 0.150 |
Why?
|
Cyclin D | 1 | 2017 | 71 | 0.140 |
Why?
|
Dihydrotestosterone | 1 | 2017 | 195 | 0.140 |
Why?
|
Systems Biology | 1 | 2020 | 482 | 0.140 |
Why?
|
Texas | 1 | 2017 | 410 | 0.130 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18349 | 0.130 |
Why?
|
Phosphorylation | 2 | 2017 | 8317 | 0.130 |
Why?
|
Male | 24 | 2024 | 364719 | 0.120 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2015 | 48 | 0.120 |
Why?
|
Receptor, IGF Type 1 | 1 | 2017 | 384 | 0.120 |
Why?
|
Signal Transduction | 9 | 2020 | 23645 | 0.110 |
Why?
|
Cell Cycle | 2 | 2017 | 2932 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2059 | 0.110 |
Why?
|
Mice, Knockout | 2 | 2024 | 14488 | 0.110 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3445 | 0.110 |
Why?
|
Estrogen Replacement Therapy | 1 | 2020 | 1209 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 2011 | 254 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1151 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1169 | 0.100 |
Why?
|
Adipocytes | 1 | 2020 | 1197 | 0.100 |
Why?
|
Citrates | 1 | 2013 | 134 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2015 | 757 | 0.100 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 625 | 0.100 |
Why?
|
Transfection | 2 | 2017 | 5755 | 0.100 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5889 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 794 | 0.100 |
Why?
|
Mice | 9 | 2024 | 82029 | 0.100 |
Why?
|
Myosin Light Chains | 1 | 2012 | 122 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 736 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1812 | 0.100 |
Why?
|
RNA Interference | 2 | 2017 | 2832 | 0.100 |
Why?
|
Prognosis | 7 | 2022 | 30010 | 0.100 |
Why?
|
Aging | 3 | 2021 | 8744 | 0.090 |
Why?
|
Humans | 31 | 2024 | 768166 | 0.090 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2011 | 21 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1904 | 0.090 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 304 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1892 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2062 | 0.090 |
Why?
|
Cadherins | 1 | 2015 | 905 | 0.090 |
Why?
|
Animals | 11 | 2024 | 169246 | 0.090 |
Why?
|
Urinary Bladder | 2 | 2018 | 1157 | 0.090 |
Why?
|
rho-Associated Kinases | 1 | 2012 | 290 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2011 | 287 | 0.090 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 558 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2011 | 208 | 0.090 |
Why?
|
Glutamine | 1 | 2013 | 577 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2914 | 0.080 |
Why?
|
Autophagy | 1 | 2018 | 1349 | 0.080 |
Why?
|
Neoplasms | 2 | 2015 | 22371 | 0.080 |
Why?
|
Blood Vessels | 1 | 2015 | 1110 | 0.080 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1942 | 0.080 |
Why?
|
Liver | 2 | 2020 | 7577 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3329 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3568 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2187 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12252 | 0.070 |
Why?
|
Tumor Microenvironment | 2 | 2018 | 3948 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2012 | 1209 | 0.070 |
Why?
|
Erythropoietin | 1 | 2011 | 718 | 0.070 |
Why?
|
Up-Regulation | 2 | 2015 | 4146 | 0.070 |
Why?
|
Aged | 14 | 2023 | 171504 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1143 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8647 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3986 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11669 | 0.070 |
Why?
|
Organ Size | 2 | 2021 | 2267 | 0.060 |
Why?
|
Fibrosarcoma | 1 | 2007 | 313 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2007 | 590 | 0.060 |
Why?
|
Cyclin B1 | 1 | 2005 | 57 | 0.060 |
Why?
|
Cyclin B | 1 | 2005 | 104 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4978 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59629 | 0.060 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2007 | 617 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1750 | 0.060 |
Why?
|
Antigens, CD | 1 | 2015 | 4035 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9374 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2433 | 0.060 |
Why?
|
X-Rays | 1 | 2005 | 311 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2017 | 19015 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 13053 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2892 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6526 | 0.050 |
Why?
|
Middle Aged | 12 | 2021 | 223492 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2011 | 2059 | 0.050 |
Why?
|
Urethra | 1 | 2023 | 406 | 0.050 |
Why?
|
Survival Rate | 3 | 2022 | 12840 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2333 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2020 | 65371 | 0.040 |
Why?
|
Disease Progression | 4 | 2020 | 13671 | 0.040 |
Why?
|
Marital Status | 1 | 2022 | 426 | 0.040 |
Why?
|
Cell Line, Tumor | 5 | 2015 | 17140 | 0.040 |
Why?
|
Medicine, Chinese Traditional | 1 | 2020 | 75 | 0.040 |
Why?
|
Immunotherapy | 1 | 2015 | 4755 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3620 | 0.040 |
Why?
|
Mice, Nude | 2 | 2015 | 3623 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8759 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4362 | 0.040 |
Why?
|
Isoenzymes | 2 | 2014 | 1688 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2005 | 1198 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2013 | 3187 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 24315 | 0.030 |
Why?
|
SEER Program | 1 | 2022 | 1444 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2014 | 13586 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1627 | 0.030 |
Why?
|
Urothelium | 1 | 2018 | 275 | 0.030 |
Why?
|
Adipogenesis | 1 | 2018 | 370 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1338 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12077 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2005 | 2954 | 0.030 |
Why?
|
Mice, SCID | 2 | 2011 | 2627 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2015 | 252 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 960 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10101 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10632 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2018 | 519 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39348 | 0.030 |
Why?
|
Sirolimus | 1 | 2020 | 1540 | 0.030 |
Why?
|
Carboxylic Acids | 1 | 2013 | 91 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13676 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1078 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 354 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2013 | 458 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 596 | 0.020 |
Why?
|
Extracellular Fluid | 1 | 2013 | 165 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11095 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2011 | 107 | 0.020 |
Why?
|
Cell Line | 1 | 2005 | 15597 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5341 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1606 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2014 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9419 | 0.020 |
Why?
|
Adiposity | 1 | 2018 | 1895 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 81762 | 0.020 |
Why?
|
Female | 7 | 2023 | 397192 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6793 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3611 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3556 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2227 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1494 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22379 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2007 | 259 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1208 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40218 | 0.020 |
Why?
|
Pericytes | 1 | 2007 | 299 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8054 | 0.010 |
Why?
|
Capillaries | 1 | 2007 | 755 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4912 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5926 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12168 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12543 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4580 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2937 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3780 | 0.010 |
Why?
|
Cognition | 1 | 2020 | 7073 | 0.010 |
Why?
|
Anemia | 1 | 2011 | 1514 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6809 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2007 | 1493 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5804 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9523 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18412 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7598 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20760 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9495 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5210 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54926 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4427 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36743 | 0.010 |
Why?
|
United States | 1 | 2020 | 73039 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23760 | 0.010 |
Why?
|
Adult | 1 | 2020 | 223646 | 0.000 |
Why?
|